Ibrance (Palbocicilib)

Oral therapy for women with hormone-receptor Positive (ER+ and/or PR+) HER2- Metastatic Breast Cancer.

When used in combination with a hormone therapy, may delay disease progression.

• Letrozole
• Fulvestrant

Common Side Effects that affect nutrition:

• Fatigue
• SOB
• Low RBC/Low Platelets (contributes to fatigue)
• Other less common: nausea, sore mouth, diarrhea/constipation, loss of appetite

Serious Side Effects:

• Neutropenia (low white blood cell counts)
• Blood clots